Expanding the Role of Pharmacists in the Administration of Long-Acting Injectable Antipsychotic Medications

Pharmacy Times, July 2019 Gastrointestinal Issues, Volume 85, Issue 7

Continuing education for administration of long-acting injectable antipsychotic medications.


Misty L. Gonzalez, PharmD, BCPP, Clinical Associate Professor, Southern Illinois University, Edwardsville School of Pharmacy, Edwardsville, Illinois

Danielle Moses, PharmD, BCPP, Psychiatric Pharmacist, SSM Health DePaul Hospital, St. Louis, Missouri

Educational Objectives

At the completion of this activity, the participant will be able to:

  • Examine nonadherence data among patients with mental illness
  • Identify legislative changes that have expanded the role of pharmacists in providing long-acting injectable antipsychotic (LAIA) medications to patients
  • Explore FDA-approved formulations and administration of LAIAs
  • Demonstrate the appropriate administration of LAI therapies in practice

Target Audience: Pharmacists

Activity Type: Application

Release Date: July 19, 2019

Expiration Date: July 19, 2020

Estimated Time to Complete Activity: 2.5 hours

Fee: This lesson is offered for free at www.pharmacytimes.org